Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT -- Ignore unavailable to you. Want to Upgrade?

To: SwampDogg who wrote (351)	2/4/2000 4:24:00 PM
From: the Chief	Read Replies (1) \| Respond to of 500

Depends on how you look at it. One of WHTs revenue streams was to sell the rights to companies for its TET system. Now they will be in competition with ABMD, but ABMD has the US wired. Don't get me wrong, I love WHT ...you can see i am one of the original posters......if they are ontime with the animal trials and things progress smoothly than all will be fine, but I will cover before that. the Chief

To: SwampDogg who wrote (351)	2/4/2000 5:06:00 PM
From: Steve G.	Read Replies (1) \| Respond to of 500

Here is the news, it appears to me that World Heart is making it clear they will challenge even minor infringements such as this. World Heart Corp. has lost its legal battle with Abiomed Inc. with respect to alleged breach of contract and misappropriation of trade secrets. The verdict in the jury trial came down on Friday. The jury found in favour of the Abiomed. "The effect of this decision is to determine that Abiomed's transcutaneous energy transfer system does not incorporate or rely upon trade secrets that belong to WorldHeart. The decision does not affect WorldHeart's ownership of its own transcutaneous energy technology,' said Rod Bryden, president and CEO of WorldHeart. "We have given notice to the court of our intention to file a motion to set aside the decision, sanction the defendant and seek a new trial on the grounds of misconduct of the defendant by failure to provide full and timely disclosure of evidence during pre-trial discovery," said Bryden.